Law360, New York (July 05, 2012, 2:48 PM ET) -- Robins Kaplan Miller & Ciresi LLP has boosted its life sciences and Hatch-Waxman intellectual property group in New York with the addition of a former Wilson Sonsini Goodrich & Rosati PC attorney who specializes in generic pharmaceutical patent cases.
Jeffrey Hovden, who is joining the firm as a partner, focuses on such cases under the Hatch-Waxman Act and within the biotechnology industry with clients including generics makers and name-brand drugmakers. The firm announced the addition of Hovden on June 25.
Ronald J. Schutz, the chairman of...
Robins Kaplan Adds Wilson Sonsini Drug Patent Atty In NY
To view the full article, take a free trial now.
